Skip to content

Insider · CIK 0001867165

Deepa Prasad

director

Files at DSGN (Design Therapeutics, Inc.). First filing Dec 19, 2024, latest Dec 19, 2024.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $24k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

DSGN: Design Therapeutics, Inc.

DSGNOct 9, 2026 · close 11.65

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
20Weak
DSGNsell
Design Therapeutics, Inc.
$24k
3,806 shares
-16%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 10, 2025DSGN
Design Therapeutics, Inc.
AGrant or award
Stock Option (right to buy)derivative
+19,000$0.00$019,000Jun 12, 2025
Dec 18, 2024DSGN
Design Therapeutics, Inc.
SOpen-market sale
Common Stock
-3,806$6.27$24k20,000Dec 19, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Deepa Prasad: insider trades and track record | InsiderTell